I found the Rutgers Pain Bulletin Board posting credible. I believe, but I don't know, that the poster is the real thing.
I also found the recently reported research at the University of Utah in the US to be very credible.
Both these factors form part of the calculus that leads me to predict success for ACV1 - and better things for MBP.
Also, your basis for projecting a $4 share price are not optimistic. Your projected royalty is on the low side as is your projected PE ratio, making your $4 a bit conservative longer term. IMHO.
ACV1 is likely to the mirror image of the AOD9604 fiasco. Folks are now gunshy of MBP for all the very good reasons that have been written all about on this board.
But that may be blinding some folks to the very real situation that will soon be unfolding with ACV1.
Folks will be amazed at how fast bad press can be turned into good, and how fast a stock can climb as well as fall. Look at how EMIS in the US went from just over a dollar to $80 in four years a few years ago.
Just don't ask me where EMIS is today - that's not my point. I'm only saying that things can change in a heartbeat.
I found the Rutgers Pain Bulletin Board posting credible. I...
Add to My Watchlist
What is My Watchlist?